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While genome-wide association studies (GWAS) and whole-exome sequencing (WES) remain important components of human disease research, the future lies in whole-genome sequencing (WGS), as it inarguably provides more complete data. The central challenge posed by WGS is one of scale. Genetic disease studies require thousands of samples to obtain adequate power, and the resulting WGS datasets are hundreds of gigabytes in size and contain tens of millions of variants. Manipulating data at this scale is difficult. To find the alleles that contribute to traits of interest, two steps must occur. First, the variants identified in a sequencing experiment need to be described in a process called annotation, and second, the relevant alleles need to be identified based on those descriptions in a procedure called variant filtering.
Annotating and filtering large numbers of variant alleles requires specialty software.
Existing annotators, such as ANNOVAR 1 , VEP 2 , GEMINI 3 , and SeqAnt 1.0 4 have played an important research role, and are sufficient for small to medium experiments (e.g.,10s to 100s of WES samples). However, they require significant computer science training to use in offline, distributed computing environments, and have substantial restrictions on the maximum size of the data they will annotate online. Existing variant filtering solutions are also limited, with complicated analyses generally requiring researchers to program custom scripts, which can result in errors that impact reproducibility 5 . Therefore, annotation and filtering are not readily accessible to most scientists, and even bioinformaticians face challenges of cost and complexity.
Here we introduce an online, cloud-based application called SeqAnt 2.0 that simplifies variant annotation and filtering. It is the first program capable of annotating sequencing experiments on the scale of thousands of whole-genome samples and tens of millions of variants in a web browser, while also integrating the first natural-language search engine that enables filtering using English phrases. SeqAnt 2.0 makes it possible to efficiently find alleles of . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/146514 doi: bioRxiv preprint first posted online Jun. 6, 2017; interest without significant computer science training, improves reproducibility, and reduces annotation and filtering costs for large experiments.
SeqAnt's annotation and filtering functions are exposed through a public web application (https://seqant.emory.edu/). Creating an annotation is as simple as registering an account, selecting the genome and assembly used to make the variant call format (VCF) 6 or SNP-format 7 files, and uploading these files from a computer or Amazon S3 bucket. Annotation occurs in the cloud, where instances of the SeqAnt 2.0 annotation engine process the data and send the results back to the web application for storage and display (Figure 1 ). 2) The data is processed in the cloud, adding descriptions from public databases (e.g. RefSeq, dbSNP, Clinvar, and others).
3) The annotated results can be filtered using SeqAnt's natural-language search engine, and any search results can be saved. 4) Annotated experiments and saved results can be viewed online, downloaded as tab-delimited text to a local computer, or uploaded to an Amazon S3 bucket.
. supports Boolean operators, numerical ranges, and regular expressions. The search engine has a built-in dictionary of synonymous terms, for instance equating "missense" and "nonsynonymous", and allows users to define their own synonyms, which is helpful for uncovering nuanced relationships. For instance, it is possible to label trios to uncover de novo variants or to test allele transmission models. SeqAnt 2.0 also provides search tools, which are small programs, accessible by a single mouse click, that dynamically modify any query to generate Figure 1) . When tested offline to gauge performance in the absence of web-related limitations, SeqAnt was 58x faster than ANNOVAR and 425x faster than VEP, completing Phase 3 in less than 6 hours (Supplementary Table 1 ). By contrast, ANNOVAR was unable to finish either annotation due to memory requirements, and VEP annotated Phase 3 at a rate of 10 variants per second, indicating that it would need at least 98 days to complete that data set. Critically, SeqAnt's run time grew linearly with the number of submitted genotypes, suggesting that it could handle even hundreds of thousands of samples within days. A detailed comparison of the exact settings used is given (Supplementary Dataset 1 and Supplementary
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Dataset 2).
Next, we explored SeqAnt's ability to filter the 84.7 million annotated Phase 3 variants (Table 1) . No other tested online program could load the data. First, we used SeqAnt's naturallanguage search engine to find all alleles in exonic regions by entering the term "exonic" 
results to rare, predicted deleterious alleles, we queried "cadd > 20 maf < .001 pathogenic expert review missense" (65 alleles, 0.13 ± 0.05s). This search query could be written using partial words ("pathogen"), possessive nouns ("expert's"), different tenses ("reviews"), and synonyms ("nonsynonymous") without changing the results. The SeqAnt search engine allows for rapid and detailed data exploration. For example, searching for "early-onset breast cancer" and 2,504 samples, were filtered using the SeqAnt 2.0 natural-language search engine online. Queries in groups 2, 3, and 4 contain phrasing differences. "Time" is the number of seconds taken to return matching alleles, averaged from three consecutive repetitions of each query. "Variants" is the number of annotated sites returned from each search query.
"Tr:Tv" is the transition to transversion ratio automatically calculated for each query by the search engine.
. CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/146514 doi: bioRxiv preprint first posted online Jun. 6, 2017; returned alleles in BRCA1 and BRCA2, and querying "pathogenic nonsense eds" returned a nonsense variant in PLOD1 that is reportedly associated with Ehlers-Danlos syndrome.
A potential limitation of SeqAnt's comparison to other software is that sophisticated users could implement distributed computing algorithms like MapReduce 15 , and spread annotation workloads across multiple servers to improve performance. Additionally, we could have limited the number or types of annotations applied to the data, especially whole-genome annotation sources (e.g., CADD), to improve performance of the other software. SeqAnt demonstrates that these workarounds are unnecessary to achieve reasonable run-times for large datasets online and offline. Finally, while SeqAnt's natural-language search engine significantly reduces the difficulty of filtering annotated variants, it is potentially limited when using partial search terms that match multiple words in the query. This is easily avoided by using exact phrases (e.g., by quoting terms) or using user-specified synonyms.
To date, identifying alleles of interest in large sequencing experiments has been technically challenging. SeqAnt 2.0 simplifies this process by introducing the first online application capable of annotating large whole-genome datasets and then filtering them using a natural-language search engine. It requires no computer science experience to use and is available for many species, including homo sapiens, m. musculus, d. melanogaster, c. elegans, and s. cerevisiae. As sequencing experiments expand in size to and scope, SeqAnt 2.0's integrated capabilities will prove invaluable for reproducible annotation and filtering.
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